Received: 29 August 2022
Accepted: 24 October 2022
First Online: 14 November 2022
: The study was conducted in conformity with International Conference on Harmonization E6 Good Clinical Practice (GCP) guidelines and the FDA Guidance for GCP in clinical trials with prior approval by IntegReview IRB. A signed consent form was obtained from each participant.
: Not applicable.
: Life Extension is a nutraceutical company based in USA who sells the Pro-Resolving Mediators and Curcumin Elite™ Turmeric Extract supplements used in the study.